Literature DB >> 22409949

Kerasoft IC compared to Rose-K in the management of corneal ectasias.

Fernando J Fernandez-Velazquez1.   

Abstract

PURPOSE: To determine the efficacy of the KeraSoft(®) IC (KIC) (Ultravision International Limited, Bedfordshire, UK), a silicone hydrogel contact lens, for the optical management of non-surgical corneal ectasias and to compare it with the Rose-K 2 RGP contact lens.
METHODS: In a retrospective study ninety-four eyes fitted with KIC (group A) were compared with seventy-seven eyes fitted with Rose-K(®) RGP lenses as a control group. Ocular diagnoses, corneal curvature by topography, refraction, best spectacle-corrected visual acuity (BSCVA), and age at time of fitting were noted. Outcome data included average daily wearing time, contact lens complications, visual acuity with the lens (BCLCVA), power of the lenses and length of follow-up.
RESULTS: Differences in either BCLCVA or wearing time could not be statistically established (p = 0.63, p = 0.15) between both groups. More biomicroscopic complications were found in the RGP group, basically corneal staining (P < 0.0001). In the KIC group, BCLCVA was statistically similar between types of ectasia (p = 0.19) as well as in mild and moderate keratoconus (p = 0.45).
CONCLUSIONS: KIC is a good alternative for the optical management of irregular corneal astigmatism in non surgical corneal ectasias such as keratoconus and pellucid marginal degeneration.
Copyright © 2012 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22409949     DOI: 10.1016/j.clae.2012.02.005

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  11 in total

Review 1.  Current perspectives in the management of keratoconus with contact lenses.

Authors:  Li Lim; Elizabeth Wen Ling Lim
Journal:  Eye (Lond)       Date:  2020-07-08       Impact factor: 3.775

2.  A retrospective analysis of vision correction and safety in keratoconus patients wearing Toris K soft contact lenses.

Authors:  Pinar Sultan; Cezmi Dogan; Guzin Iskeleli
Journal:  Int Ophthalmol       Date:  2016-02-19       Impact factor: 2.031

3.  Evaluation of rigid gas permeable lens fitting in keratoconic patients with optical coherence tomography.

Authors:  Amal M Elbendary; Waleed Abou Samra
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-08       Impact factor: 3.117

4.  Contact lens impact on quality of life in keratoconus patients: rigid gas permeable versus soft silicone-hydrogel keratoconus lenses.

Authors:  Elvin Hatice Yildiz; Mesut Erdurmus; Emine Savran Elibol; Banu Acar; Ece Turan Vural
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

Review 5.  Nonsurgical Procedures for Keratoconus Management.

Authors:  L Rico-Del-Viejo; M Garcia-Montero; J L Hernández-Verdejo; S García-Lázaro; F J Gómez-Sanz; A Lorente-Velázquez
Journal:  J Ophthalmol       Date:  2017-12-21       Impact factor: 1.909

Review 6.  Updates on Managements for Keratoconus.

Authors:  Mehrdad Mohammadpour; Zahra Heidari; Hassan Hashemi
Journal:  J Curr Ophthalmol       Date:  2017-12-06

7.  Clinical performance of KeraSoft(®) IC in irregular corneas.

Authors:  Stephanie Su; Lynette Johns; Marjorie J Rah; Robert Ryan; Joseph Barr
Journal:  Clin Ophthalmol       Date:  2015-10-22

Review 8.  Contact lens in keratoconus.

Authors:  Varsha M Rathi; Preeji S Mandathara; Srikanth Dumpati
Journal:  Indian J Ophthalmol       Date:  2013-08       Impact factor: 1.848

9.  Clinical Performance of Toris K Contact Lens in Patients with Moderate to Advanced Keratoconus: A Real Life Retrospective Analysis.

Authors:  Ihsan Yilmaz; Ferah Ozcelik; Berna Basarir; Gokhan Demir; Gonul Durusoy; Muhittin Taskapili
Journal:  J Ophthalmol       Date:  2016-04-06       Impact factor: 1.909

10.  Fitting Tips and Visual Rehabilitation of Irregular Cornea with a New Design of Corneoscleral Contact Lens: Objective and Subjective Evaluation.

Authors:  Waleed Ali Abou Samra; Amani E Badawi; Hanem Kishk; Ayman Abd El Ghafar; Mohamed M Elwan; Hossam Youssef Abouelkheir
Journal:  J Ophthalmol       Date:  2018-02-01       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.